Search

Search Constraints

You searched for: Author/Creator Mummery, Catherine J.

Search Results

1. [O2–17–02]: DISCOVERY AND EARLY CLINICAL DEVELOPMENT OF IONIS‐MAPTRX, THE FIRST TAU‐LOWERING ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH MILD AD. (1st July 2017)

2. [P1–335]: THEMES AND VARIATIONS IN PPA: A CLINICAL AND NEUROBIOLOGICAL ANALYSIS OF THE UCL COHORT. (1st July 2017)

5. Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Issue 5 (13th October 2022)

6. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. (September 2021)

7. Auditory conflict and congruence in frontotemporal dementia. (September 2017)

8. Characterization of amyloid‐related imaging abnormality in the DIAN‐TU‐001 trial. (31st December 2021)

9. Current directions in tau research: Highlights from Tau 2020. Issue 5 (28th September 2021)

10. ENVISION: A phase 3b/4 randomized, double‐blind, placebo‐controlled, parallel‐group study to verify the clinical benefit of aducanumab in participants with early Alzheimer's disease. (20th December 2022)